Immunofluorescence experiments showed that CD63 was significantly aggregated in pancreatic cancer intracellularly after knockdown of Exo70 or ES2 treatment (Figure 4E,F). This evidence concerns the gene EXOC7 and familial pancreatic carcinoma.